查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
免疫学全球市场规模调查和预测，按药物类别按疾病适应症，按分销渠道，按地区分析，2022-2029
市场调查报告书
商品编码
1261226

免疫学全球市场规模调查和预测，按药物类别按疾病适应症，按分销渠道，按地区分析，2022-2029

Global Immunology Market Size study & Forecast, by Drug Class by Disease Indication, by Distribution Channel and Regional Analysis, 2022-2029
出版日期: | 出版商: Bizwit Research & Consulting LLP | 英文 | 商品交期: 2-3个工作天内

价格

2021 年全球免疫学市场价值约为 979.3 亿美元，预计在 2022-2029 年预测期内将以超过 8.5% 的健康增长率增长。

免疫学是医学和生物学的研究领域，重点关注和研究免疫系统。 免疫系统以多种方式保护个体免受感染。 免疫药物和物质通过增强或抑制免疫系统来改变免疫反应。 免疫药物和物质用于治疗和预防感染性疾病和自身免疫和免疫性疾病，如1型糖尿病、类风湿性关节炎和银屑病关节炎。 全球市场的增长受到生物仿製药需求激增、免疫疾病意识增强以及预防医学需求增加等因素的推动。

此外，自身免疫性疾病发病率的增加已成为决定全球市场需求的重要因素。 美国国家干细胞基金会的一项研究估计，在 80 多种自身免疫性疾病中，至少有一种会影响全球约 4% 的人。 例如，患者对这些药物的需求不断增加，导致各种市场进入者专注于开发新产品并将其推向市场。 例如，Lupin 在 2020 年 9 月宣布了一种仿製类风湿性关节炎药物。 同样，截至 2022 年 4 月，强生服务公司拥有约 20 个针对各种自身免疫性疾病适应症的管道项目，包括银屑病关节炎、类风湿性关节炎和炎症性肠病，以及免疫学领域。因此，赛诺菲大约有 30 个管道项目. 这导致自身免疫性疾病的患病率增加，人们更加关注为其引入治疗方法，从而推动了市场的增长。 此外，越来越多地引入新疗法和越来越多的监管机构批准的产品也在可预见的几年内提供了各种有利可图的机会。 然而，高昂的治疗成本和与产品相关的副作用阻碍了整个 2022-2029 年预测期内的市场增长。

全球免疫学市场研究中考虑的主要区域是亚太地区、北美、欧洲、拉丁美洲和世界其他地区。 由于其先进的医疗基础设施和不断增加的研发投资，北美在销售方面占据了市场主导地位。 另一方面，由于自身免疫性疾病的增加、预防医学需求的增加以及药物批准的增加等因素，预计亚太地区在预测期内将以最高的复合年增长率增长。

本研究的目的是阐明近年来各个细分市场和国家/地区的市场规模，并预测未来几年的市场规模。 该报告旨在捕捉被调查国家工业的定性和定量方面的情况。

它还提供了关键方面的详细信息，例如决定市场未来增长的驱动因素和挑战。 此外，它还包含供利益相关者投资的潜在微观市场机会，以及对主要参与者的竞争格局和产品供应的深入分析。 .

内容

第 1 章执行摘要

  • 市场概况
  • 2019-2029 年各细分市场的全球市场估计和预测
    • 免疫学市场，按地区划分，2019-2029 年
    • 免疫学市场，按药物类别，2019-2029 年
    • 免疫学市场，按疾病适应症分类，2019-2029 年
    • 免疫学市场，按分销渠道，2019-2029 年
  • 主要趋势
  • 调查方法
  • 调查先决条件

第 2 章全球免疫学市场定义和范围

  • 调查目的
  • 市场定义和范围
    • 调查范围
    • 工业发展
  • 本次调查涵盖的年份
  • 货币兑换率

第 3 章全球免疫学市场动态

  • 免疫学市场影响分析 (2019-2029)
    • 市场驱动因素
      • 自身免疫性疾病的增加
      • 对生物仿製药的需求激增
    • 市场挑战
      • 昂贵的医疗费用
      • 与产品相关的不良事件
    • 市场机会
      • 更多地引入创新产品
      • 监管机构批准的产品数量增加

第四章全球免疫学市场行业分析

  • 波特 5 力模型
    • 供应商的议价能力
    • 买家的议价能力
    • 新进入者的威胁
    • 替代品的威胁
    • 竞争公司之间的敌对关係
  • 波特 5 力模型的未来方法 (2019-2029)
  • 害虫分析
    • 政治
    • 经济的
    • 社交
    • 技术
  • 主要投资机会
  • 关键成功策略
  • 业内人士的前景
  • 分析师的建议和结论

第 5 章风险评估：COVID-19 的影响

  • 评估 COVID-19 对行业的总体影响
  • COVID-19 之前和 COVID-19 之后的市场情景

第 6 章全球免疫学市场：按药物类别分类

  • 市场概况
  • 全球免疫学市场：按药物类别、性能-潜力分析
  • 2019-2029 年按药物类别划分的免疫学全球市场估计和预测
  • 免疫学市场，按细分市场分析
    • 单克隆抗体
    • 免疫抑製剂
    • 融合蛋白
    • 其他

第 7 章全球免疫学市场：按疾病适应症分类

  • 市场概况
  • 全球免疫学市场：按适应症分类的表现 - 潜力分析
  • 2019-2029 年按疾病分类的全球免疫学市场估计和预测
  • 免疫学市场，按细分市场分析
    • 类风湿性关节炎
    • 银屑病关节炎
    • 斑块状银屑病
    • 强直性脊柱炎
    • 炎症性肠病
    • 其他

第 8 章全球免疫学市场：按分销渠道

  • 市场概况
  • 全球免疫学市场：按分销渠道、性能-潜力分析
  • 2019-2029 年按分销渠道划分的免疫学全球市场估计和预测
  • 免疫学市场，按细分市场分析
    • 医院药房
    • 零售药房
    • 在线药店

第 9 章全球免疫学市场：区域分析

  • 免疫学市场，按地区划分的市场概况
  • 北美
    • 美国
      • 2019-2029 年按药物类别的估计和预测
      • 2019-2029 年按疾病和适应症分类的估计和预测
      • 2019-2029 年各分销渠道的估计和预测
    • 加拿大
  • 欧洲免疫学市场概况
    • 英国
    • 德国
    • 法国
    • 西班牙
    • 意大利
    • 其他欧洲
  • 亚太免疫学市场概况
    • 中国
    • 印度
    • 日本
    • 澳大利亚
    • 韩国
    • 其他亚太地区
  • 拉丁美洲免疫学市场概况
    • 巴西
    • 墨西哥
    • 其他拉丁美洲地区
  • 世界其他地方

第 10 章衝突信息

  • 顶级市场策略
  • 公司简介
    • 艾伯维公司
      • 关键信息
      • 概览
      • 财务（仅当数据可用时）
      • 产品概述
      • 近期趋势
    • Janssen Global Services, LLC
    • Eli Lilly and Company
    • Novartis AG
    • Pfizer Inc.
    • Bristol-Myers Squibb Company
    • Merck Sharp & Dohme Corp.
    • F. Hoffmann-La Roche Ltd.
    • Amgen Inc.
    • Astellas Pharma Inc.

第 11 章研究过程

  • 研究过程
    • 数据挖掘
    • 分析
    • 市场评估
    • 验证
    • 出版
  • 调查的特点
  • 调查先决条件

Global Immunology Market is valued at approximately USD 97.93 billion in 2021 and is anticipated to grow with a healthy growth rate of more than 8.5% over the forecast period 2022-2029. Immunology is the field of medical and biological research that focuses and studies the immune system. The immune system protects individuals from infection in numerous ways. by enhancing or inhibiting the immune system, immunology medications and substances alter the immunological response. Immunology drugs or agents are used to treat or prevent infections as well as several autoimmune and immunological diseases such type 1 diabetes, rheumatoid arthritis, and psoriatic arthritis. The global market growth is primarily driven by the factors such as a surge in demand for biosimilars, growing awareness about immunological diseases, coupled with the increasing demand for preventive care.

In addition, the rise in incidences of autoimmune disorders is a key factor that is stipulating the market demand in the global market. A study by the National Stem Cell Foundation estimates that at least one of 80 or more autoimmune illnesses affects about 4% of people around the world. For instance, various market participants are focusing on creating and introducing new products to the market as a result of the growing demand for these medications among patients. For instance, Lupin introduced a generic rheumatoid arthritis medication in September 2020. Likewise, As of April 2022, there were approximately 20 pipeline projects from Johnson & Johnson Services, Inc. for a variety of autoimmune indications, including psoriatic arthritis, rheumatoid arthritis, inflammatory bowel disease, and others, and approximately 30 pipeline projects from Sanofi in the immunology segment. Thereby, the increasing prevalence of autoimmune disorders and growing emphasis on introducing its treatments is boosting the market growth. Moreover, the rising introduction of novel therapies, as well as the increasing product approvals by regulatory agencies are presenting various lucrative opportunities over the forecasting years. However, the high cost of treatment and adverse effects associated with the product are hampering the market growth throughout the forecast period of 2022-2029.

The key regions considered for the Global Immunology Market study include Asia Pacific, North America, Europe, Latin America, and the Rest of the World. North America dominated the market in terms of revenue, owing to the availability of advanced healthcare infrastructure, along with growing investment on research and development activities. Whereas, the Asia Pacific is also expected to grow with the highest CAGR during the forecast period, owing to factors such as rising occurrence of autoimmune conditions, surging demand for preventive care, and increasing drug approvals in the regional market space.

Major market players included in this report are:

  • AbbVie, Inc.
  • Janssen Global Services, LLC
  • Eli Lilly and Company
  • Novartis AG
  • Pfizer Inc.
  • Bristol-Myers Squibb Company
  • Merck Sharp & Dohme Corp.
  • F. Hoffmann-La Roche Ltd.
  • Amgen Inc.
  • Astellas Pharma Inc.

Recent Developments in the Market:

  • In June 2022, Eli Lilly and Company received the U.S. FDA approval for its OLUMIANT- a first-in-disease systemic treatment that is specially developed for adults with severe alopecia areata (AA), an autoimmune disorder.
  • In April 2022, AbbVie Inc. received the U.S. FDA approval for its RINVOQ to provide treatment to adult patients with active ankylosing spondylitis.
  • In March 2022, Pfizer Inc. announced that the company acquired Arena Pharmaceuticals, a company that primarily focuses on advancing innovative potential therapies to cure several immuno-inflammatory diseases. The objective of this acquisition is to expand Pfizer Inc. product portfolio.

Global Immunology Market Report Scope:

  • Historical Data: 2019-2020-2021
  • Base Year for Estimation: 2021
  • Forecast period: 2022-2029
  • Report Coverage: Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
  • Segments Covered: Drug Class, Disease Indication, Distribution Channel, Region
  • Regional Scope: North America; Europe; Asia Pacific; Latin America; Rest of the World
  • Customization Scope: Free report customization (equivalent up to 8 analyst's working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below.

By Drug Class:

  • Monoclonal Antibody
  • Immunosuppressants
  • Fusion Proteins
  • Others

By Disease Indication:

  • Rheumatoid Arthritis
  • Psoriatic Arthritis
  • Plaque Psoriasis
  • Ankylosing Spondylitis
  • Inflammatory Bowel Disease
  • Others

By Distribution Channel:

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies

By Region:

  • North America
  • U.S.
  • Canada
  • Europe
  • UK
  • Germany
  • France
  • Spain
  • Italy
  • ROE
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • RoAPAC
  • Latin America
  • Brazil
  • Mexico
  • RoLA
  • Rest of the World

Table of Contents

Chapter 1. Executive Summary

  • 1.1. Market Snapshot
  • 1.2. Global & Segmental Market Estimates & Forecasts, 2019-2029 (USD Billion)
    • 1.2.1. Immunology Market, by Region, 2019-2029 (USD Billion)
    • 1.2.2. Immunology Market, by Drug Class, 2019-2029 (USD Billion)
    • 1.2.3. Immunology Market, by Disease Indication, 2019-2029 (USD Billion)
    • 1.2.4. Immunology Market, by Distribution Channel, 2019-2029 (USD Billion)
  • 1.3. Key Trends
  • 1.4. Estimation Methodology
  • 1.5. Research Assumption

Chapter 2. Global Immunology Market Definition and Scope

  • 2.1. Objective of the Study
  • 2.2. Market Definition & Scope
    • 2.2.1. Scope of the Study
    • 2.2.2. Industry Evolution
  • 2.3. Years Considered for the Study
  • 2.4. Currency Conversion Rates

Chapter 3. Global Immunology Market Dynamics

  • 3.1. Immunology Market Impact Analysis (2019-2029)
    • 3.1.1. Market Drivers
      • 3.1.1.1. Increasing incidences of autoimmune disorders
      • 3.1.1.2. Surge in demand for biosimilars
    • 3.1.2. Market Challenges
      • 3.1.2.1. High cost of treatment
      • 3.1.2.2. Adverse effects associated with product
    • 3.1.3. Market Opportunities
      • 3.1.3.1. Rising Introduction of innovative products
      • 3.1.3.2. Increasing product approvals by regulatory agencies

Chapter 4. Global Immunology Market Industry Analysis

  • 4.1. Porter's 5 Force Model
    • 4.1.1. Bargaining Power of Suppliers
    • 4.1.2. Bargaining Power of Buyers
    • 4.1.3. Threat of New Entrants
    • 4.1.4. Threat of Substitutes
    • 4.1.5. Competitive Rivalry
  • 4.2. Futuristic Approach to Porter's 5 Force Model (2019-2029)
  • 4.3. PEST Analysis
    • 4.3.1. Political
    • 4.3.2. Economical
    • 4.3.3. Social
    • 4.3.4. Technological
  • 4.4. Top investment opportunity
  • 4.5. Top winning strategies
  • 4.6. Industry Experts Prospective
  • 4.7. Analyst Recommendation & Conclusion

Chapter 5. Risk Assessment: COVID-19 Impact

  • 5.1. Assessment of the overall impact of COVID-19 on the industry
  • 5.2. Pre COVID-19 and post COVID-19 Market scenario

Chapter 6. Global Immunology Market, by Drug Class

  • 6.1. Market Snapshot
  • 6.2. Global Immunology Market by Drug Class, Performance - Potential Analysis
  • 6.3. Global Immunology Market Estimates & Forecasts by Drug Class 2019-2029 (USD Billion)
  • 6.4. Immunology Market, Sub Segment Analysis
    • 6.4.1. Monoclonal Antibody
    • 6.4.2. Immunosuppressants
    • 6.4.3. Fusion Proteins
    • 6.4.4. Others

Chapter 7. Global Immunology Market, by Disease Indication

  • 7.1. Market Snapshot
  • 7.2. Global Immunology Market by Disease Indication, Performance - Potential Analysis
  • 7.3. Global Immunology Market Estimates & Forecasts by Disease Indication 2019-2029 (USD Billion)
  • 7.4. Immunology Market, Sub Segment Analysis
    • 7.4.1. Rheumatoid Arthritis
    • 7.4.2. Psoriatic Arthritis
    • 7.4.3. Plaque Psoriasis
    • 7.4.4. Ankylosing Spondylitis
    • 7.4.5. Inflammatory Bowel Disease
    • 7.4.6. Others

Chapter 8. Global Immunology Market, by Distribution Channel

  • 8.1. Market Snapshot
  • 8.2. Global Immunology Market by Distribution Channel, Performance - Potential Analysis
  • 8.3. Global Immunology Market Estimates & Forecasts by Distribution Channel 2019-2029 (USD Billion)
  • 8.4. Immunology Market, Sub Segment Analysis
    • 8.4.1. Hospital Pharmacies
    • 8.4.2. Retail Pharmacies
    • 8.4.3. Online Pharmacies

Chapter 9. Global Immunology Market, Regional Analysis

  • 9.1. Immunology Market, Regional Market Snapshot
  • 9.2. North America Immunology Market
    • 9.2.1. U.S. Immunology Market
      • 9.2.1.1. Drug Class breakdown estimates & forecasts, 2019-2029
      • 9.2.1.2. Disease Indication breakdown estimates & forecasts, 2019-2029
      • 9.2.1.3. Distribution Channel breakdown estimates & forecasts, 2019-2029
    • 9.2.2. Canada Immunology Market
  • 9.3. Europe Immunology Market Snapshot
    • 9.3.1. U.K. Immunology Market
    • 9.3.2. Germany Immunology Market
    • 9.3.3. France Immunology Market
    • 9.3.4. Spain Immunology Market
    • 9.3.5. Italy Immunology Market
    • 9.3.6. Rest of Europe Immunology Market
  • 9.4. Asia-Pacific Immunology Market Snapshot
    • 9.4.1. China Immunology Market
    • 9.4.2. India Immunology Market
    • 9.4.3. Japan Immunology Market
    • 9.4.4. Australia Immunology Market
    • 9.4.5. South Korea Immunology Market
    • 9.4.6. Rest of Asia Pacific Immunology Market
  • 9.5. Latin America Immunology Market Snapshot
    • 9.5.1. Brazil Immunology Market
    • 9.5.2. Mexico Immunology Market
    • 9.5.3. Rest of Latin America Immunology Market
  • 9.6. Rest of The World Immunology Market

Chapter 10. Competitive Intelligence

  • 10.1. Top Market Strategies
  • 10.2. Company Profiles
    • 10.2.1. AbbVie, Inc.
      • 10.2.1.1. Key Information
      • 10.2.1.2. Overview
      • 10.2.1.3. Financial (Subject to Data Availability)
      • 10.2.1.4. Product Summary
      • 10.2.1.5. Recent Developments
    • 10.2.2. Janssen Global Services, LLC
    • 10.2.3. Eli Lilly and Company
    • 10.2.4. Novartis AG
    • 10.2.5. Pfizer Inc.
    • 10.2.6. Bristol-Myers Squibb Company
    • 10.2.7. Merck Sharp & Dohme Corp.
    • 10.2.8. F. Hoffmann-La Roche Ltd.
    • 10.2.9. Amgen Inc.
    • 10.2.10. Astellas Pharma Inc.

Chapter 11. Research Process

  • 11.1. Research Process
    • 11.1.1. Data Mining
    • 11.1.2. Analysis
    • 11.1.3. Market Estimation
    • 11.1.4. Validation
    • 11.1.5. Publishing
  • 11.2. Research Attributes
  • 11.3. Research Assumption

LIST OF TABLES

  • TABLE 1. Global Immunology Market, report scope
  • TABLE 2. Global Immunology Market estimates & forecasts by Region 2019-2029 (USD Billion)
  • TABLE 3. Global Immunology Market estimates & forecasts by Drug Class 2019-2029 (USD Billion)
  • TABLE 4. Global Immunology Market estimates & forecasts by Disease Indication 2019-2029 (USD Billion)
  • TABLE 5. Global Immunology Market estimates & forecasts by Distribution Channel 2019-2029 (USD Billion)
  • TABLE 6. Global Immunology Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 7. Global Immunology Market by region, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 8. Global Immunology Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 9. Global Immunology Market by region, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 10. Global Immunology Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 11. Global Immunology Market by region, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 12. Global Immunology Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 13. Global Immunology Market by region, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 14. Global Immunology Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 15. Global Immunology Market by region, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 16. U.S. Immunology Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 17. U.S. Immunology Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 18. U.S. Immunology Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 19. Canada Immunology Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 20. Canada Immunology Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 21. Canada Immunology Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 22. UK Immunology Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 23. UK Immunology Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 24. UK Immunology Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 25. Germany Immunology Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 26. Germany Immunology Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 27. Germany Immunology Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 28. France Immunology Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 29. France Immunology Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 30. France Immunology Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 31. Italy Immunology Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 32. Italy Immunology Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 33. Italy Immunology Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 34. Spain Immunology Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 35. Spain Immunology Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 36. Spain Immunology Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 37. RoE Immunology Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 38. RoE Immunology Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 39. RoE Immunology Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 40. China Immunology Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 41. China Immunology Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 42. China Immunology Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 43. India Immunology Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 44. India Immunology Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 45. India Immunology Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 46. Japan Immunology Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 47. Japan Immunology Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 48. Japan Immunology Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 49. South Korea Immunology Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 50. South Korea Immunology Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 51. South Korea Immunology Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 52. Australia Immunology Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 53. Australia Immunology Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 54. Australia Immunology Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 55. RoAPAC Immunology Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 56. RoAPAC Immunology Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 57. RoAPAC Immunology Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 58. Brazil Immunology Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 59. Brazil Immunology Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 60. Brazil Immunology Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 61. Mexico Immunology Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 62. Mexico Immunology Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 63. Mexico Immunology Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 64. RoLA Immunology Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 65. RoLA Immunology Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 66. RoLA Immunology Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 67. Row Immunology Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 68. Row Immunology Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 69. Row Immunology Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 70. List of secondary sources, used in the study of global Immunology Market
  • TABLE 71. List of primary sources, used in the study of global Immunology Market
  • TABLE 72. Years considered for the study
  • TABLE 73. Exchange rates considered

List of tables and figures and dummy in nature, final lists may vary in the final deliverable

LIST OF FIGURES

List of figures

  • FIG 1. Global Immunology Market, research methodology
  • FIG 2. Global Immunology Market, Market estimation techniques
  • FIG 3. Global Market size estimates & forecast methods
  • FIG 4. Global Immunology Market, key trends 2021
  • FIG 5. Global Immunology Market, growth prospects 2022-2029
  • FIG 6. Global Immunology Market, porters 5 force model
  • FIG 7. Global Immunology Market, pest analysis
  • FIG 8. Global Immunology Market, value chain analysis
  • FIG 9. Global Immunology Market by segment, 2019 & 2029 (USD Billion)
  • FIG 10. Global Immunology Market by segment, 2019 & 2029 (USD Billion)
  • FIG 11. Global Immunology Market by segment, 2019 & 2029 (USD Billion)
  • FIG 12. Global Immunology Market by segment, 2019 & 2029 (USD Billion)
  • FIG 13. Global Immunology Market by segment, 2019 & 2029 (USD Billion)
  • FIG 14. Global Immunology Market, regional snapshot 2019 & 2029
  • FIG 15. North America Immunology Market 2019 & 2029 (USD Billion)
  • FIG 16. Europe Immunology Market 2019 & 2029 (USD Billion)
  • FIG 17. Asia pacific Immunology Market 2019 & 2029 (USD Billion)
  • FIG 18. Latin America Immunology Market 2019 & 2029 (USD Billion)
  • FIG 19. Global Immunology Market, company Market share analysis (2021)

List of tables and figures and dummy in nature, final lists may vary in the final deliverable